This article is available online at http://www.jlr.org properties of apoA-I arise primarily through its important roles in the pathway of reverse cholesterol transport; where apoA-I stabilizes and maintains the structure of HDL particles, promotes cellular cholesterol effl ux by binding to specifi c ATP binding cassette transporters, interacts with the enzyme lecithin:cholesterol acyltransferase (LCAT) to drive the maturation of HDL particles, binds and modifi es the lipoprotein surface to facilitate enzyme reactions, and interacts with the scavenger receptor class B type 1 for selective cholesterol ester (CE) uptake by the liver for excretion ( 2-4 ).ApoA-I exists in lipid-free, lipid-poor, and lipid-bound states in plasma, and exchanges among HDL and TAGrich lipoprotein particles like very low density lipoproteins (VLDLs) and chylomicrons (CMs) ( 5 ). ApoA-I interacts primarily with the hydrocarbon chains of the phospholipids (PL) on discoidal and spherical HDLs ( 6-8 ) and may also interact with the hydrophobic CE core of spherical HDL and the hydrophobic TAG core of TAG-rich lipoproteins. The conformational fl exibility of apoA-I allows it to adopt a variety of conformations involving lipid adsorption, partial or full desorption, and fl exible unfolding and refolding in diverse physical environments to facilitate its multiple functions. Studies of the molecular mechanisms of the lipid association and the conformational fl exibility of apoA-I are essential for understanding the structure-function relationships.ApoA-I has an exon 3 encoded region (residues 1-43), and an exon 4 encoded region (residues 44-243) that contains 10 11/22-mer tandem repeat amino acid segments that are predicted to form class A and class Y amphipathic ␣ -helices (A ␣ Hs) ( 9, 10 ). These A ␣ Hs (helix 1-10) are the lipid binding motif of apoA-I and the structural basis for its multiple functions. Segment deletion and point mutation studies have elucidated the possible conformation and functions for each helical segment (11)(12)(13)(14)(15)(16) Apolipoprotein A-I (apoA-I) is a major protein of high density lipoproteins (HDLs) and is also present on large triacylglycerol (TAG)-rich lipoproteins. Reduced plasma levels of HDL and apoA-I are the key risk factors for atherosclerosis and cardiovascular disease ( 1 ). The anti-atherogenic